|
NA
|
Azilsartan Impurity 23 （美阿沙坦開環(huán)雜質(zhì) U-4）
|
|
|
METHYL2-(CHLOROMETHYL)PHENYL)PROPIONATE(MIXTURE)
|
洛索洛芬鈉雜質(zhì)P3-1對(duì)照品
|
80530-54-7
|
|
2-(4-chloromethyl-phenyl)-propionic acid ethyl ester
|
洛索洛芬鈉雜質(zhì)P4-1對(duì)照品
|
43153-03-3
|
|
2-[(4-Acetylphenyl)methyl]cyclopentan-1-one
|
洛索洛芬雜質(zhì)G
|
96824-28-1
|
|
4β-Hydroxy Cholesterol-d4 (Major)
|
4β-羥基膽固醇-[d4]
|
1363529-44-5
|
|
Decarboxy Moxifloxacin 2
|
3-脫羧莫西沙星
|
929102-25-0
|
|
ALOIN
|
蘆薈素
|
8015-61-0
|
|
N-[[(5R)-3-[3-Fluoro-4-(4-Morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]Methyl]acetaMide
|
利奈唑胺雜質(zhì)R
|
872992-20-6
|
|
1-(3,5-Dihydroxyphenyl)-2-[(1,1-diMethylethyl)(phenylMethyl)aMino]ethanone HydrobroMide
|
硫酸特布他林雜質(zhì)D
|
94109-61-2
|
|
3-Oxo-2-quinuclidinecarboxylic acid ethyl ester
|
鹽酸戊乙奎醚雜質(zhì)SM2-C
|
34286-16-3
|
|
(S)-Phenylephrine hydrochloride
|
對(duì)映異構(gòu)體
|
939-38-8
|
|
2-Anthracenecarboxaldehyde, 9,10-dihydro-4,5-dihydroxy-9,10-dioxo-
|
大黃醛
|
154658-30-7
|
|
3-[2-(methylamino)ethyl]phenol hydrobromide
|
鹽酸去氧腎上腺素雜質(zhì)G
|
61186-06-9
|
|
8-Chloro-11-fluoro-6,11-dihydro-11-(4-piperidinyl)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine
|
氟地氯雷他定
|
298220-99-2
|
|
1-NaphthaleneMethanaMine, 5,6,7,8-tetrahydro-α-Methyl-, (αR)-
|
鹽酸西那卡塞XNKS-B-3
|
851984-49-1
|
|
Cinacalcet Impurity D
|
鹽酸西那卡塞雜質(zhì)F
|
1271930-15-4
|
|
Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-phenyl-
|
布南色林INT2-D
|
132813-13-9
|
|
Cycloocta[b]pyridine, 2-chloro-5,6,7,8,9,10-hexahydro-4-(4-methoxyphenyl)-
|
布南色林INT2-I（雜質(zhì)19）
|
132813-20-8
|
|
5-[(4-amino-2-carboxyphenyl)amino]-2-hydroxybenzoic acid
|
美沙拉秦EP雜質(zhì)S（2-羥基-5-[（2-羧基-4-氨基苯基）氨基]苯甲酸）
|
1797983-23-3
|
|
N-deacetyllappaconitine
|
N-去乙酰高烏甲素
|
11033-64-0
|
|
NA
|
西地那非亞硝基雜質(zhì)
|
|
|
2,3-Difluoro-4-nitroaniline
|
2,3-二氟-4-硝基苯胺
|
1781140-23-5
|
|
cefixime
|
頭孢克肟EP雜質(zhì)C
|
108691-83-4
|
|
2-Oxazolemethanol, 2,5-dihydro-α,2,4,5-tetramethyl-
|
1-(2,4,5-三甲基-2,5-二氫噁唑-2-基)-乙醇
|
171202-48-5
|
|
L-Cefadroxil
|
頭孢羥氨芐EP雜質(zhì)D
|
144790-28-3
|
|
Pyrazine, tetramethyl-, 1-oxide (8CI,9CI)
|
2,3,5,6-四甲基吡嗪-1-氧
|
22978-83-2
|
|
Ipratropium Bromide Impurity K
|
異丙托溴銨EP雜質(zhì)K
|
17838-69-6
|
|
Clindamycin eighteen carbonate salt control
|
克林霉素十八碳酸酯鹽對(duì)照品
|
1123211-70-0
|
|
DEFLAZACORT
|
地那查可特
|
13649-88-2
|
|
Mirogabalin besylateSM1- impurity A
|
苯磺酸美洛加巴林/SM1-雜質(zhì)A
|
344428-05-3
|
|
Metoclopramide EP impurity H
|
甲氧氯普胺EP雜質(zhì)H
|
50-86-2
|
|
N-YXIPD
|
艾氟康唑雜質(zhì)81 (N-亞硝基艾氟康唑雜質(zhì)36 單體)
|
3053220-60-0
|
|
Eplerenone EP Impurity D
|
依普利酮EP雜質(zhì)D
|
209253-82-7
|
|
Paliperidone Impurity J
|
帕潘立酮雜質(zhì)J
|
1138463-56-5
|
|
Axitinib Acid
|
阿昔替尼酸
|
319462-34-5
|
|
Clindamycin EP Impurity C
|
克林霉素EP雜質(zhì)C
|
16684-06-3
|
|
Axitinib Sulfoxide
|
阿昔替尼砜
|
1348536-59-3
|
|
4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-N-cyclopropyl-7-methoxy-6-quinoline carboxamide
|
4-[3-氯-4-[[(環(huán)丙基氨基)羰基]氨基]苯氧基]-N-環(huán)丙基-7-甲氧基-6-喹啉甲酰胺
|
417717-22-7
|
|
Ibuprofen-d3
|
氘代布洛芬
|
121662-14-4
|
|
1-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl][1,2,4]triazolo[4,3-a]pyridine-1-ium-3-ol/trazodone hydrochloride USP Impurity M
|
1-[3-[4-(3-氯苯基)哌嗪-1-基]丙基][1,2,4]三唑并[4,3-a]吡啶-1-鎓-3-醇/鹽酸曲唑酮USP 雜質(zhì) M
|
157072-18-9
|
|
Rivaroxaban associated impurity 1
|
利伐沙班相關(guān)雜質(zhì) 1
|
31166-29-7
|
|
chlorosulfanylthiohypochlorite,4-(2-methylbutan-2-yl)phenol
|
4-(1,1-二甲基內(nèi)基)苯酚與二氯化二碗的聚合物
|
68555-98-6
|
|
3-Amino-2-chlorophenol
|
3-氨基-2-氯苯酚
|
56962-01-7
|
|
O-toluenesulfonic acid (2-methylbenzenesulfonic acid)
|
鄰甲苯磺酸(2-甲基苯磺酸)
|
88-20-0
|
|
Metoclopramide EP impurity A
|
甲氧氯普胺EP雜質(zhì)A
|
5608-13-9
|
|
1-((dimethylamino)methyl)-7-phenoxyisoquinolin-4-ol
|
1-甲基-4-羥基-7-苯氧基異喹啉
|
2756726-89-1
|
|
3-[4-(3-chlorophenyl)piperazin-1-yl]propan-1-ol
|
3-[4-(3-氯苯基)哌嗪-1基]丙-1-醇
|
32229-98-4
|
|
Lincomycin Impurity B
|
林可霉素B對(duì)照品
|
2520-24-3
|
|
Metoclopramide EP impurity B
|
甲氧氯普胺EP雜質(zhì)B
|
4093-31-6
|
|
Leucoson
|
利可君
|
1950-36-3
|
|
Posaconazole Enantiomer
|
泊沙康唑非對(duì)應(yīng)異構(gòu)體
|
2243785-97-7
|
|
BM2-d
|
2,4-二硝基苯基苯基醚
|
002486-07-9
|
|
4-Methoxy-1,2-phenylenediamine（SM1-1）
|
4-甲氧基-1,2-苯二胺（SM1-1）
|
102-51-2
|
|
2-Methoxy-5-nitroaniline(SM1-7)
|
2-甲氧基-5-硝經(jīng)基苯(SM1-7)
|
99-59-2
|
|
BM1-d
|
2,4-二硝基氯苯
|
97-00-7
|
|
2,3,5-trimethyl-4-nitro-1-oxidopyridin-1-ium(SM2-2)
|
2,3,5-三甲基-4-硝基吡啶氮氧化物(SM2-2)
|
86604-79-7
|
|
N-hydroxyaniline control
|
N-羥基苯胺對(duì)照品
|
100-65-2
|
|
2-[4-(2-{4-[1-(2-ethoxyethyl)-1H-benzimidazole-2-yl]-piperidine-N-oxo-1-yl}-ethyl)-phenyl]-2-methylpropionic acid
|
2-[4-（2-{4-[1-（2-乙氧基乙基）-1H-苯并咪唑-2-基]-哌啶-N-氧-1-基}-乙基）-苯基]-2-甲基丙酸
|
2069238-47-5
|
|
2-(4-(2-hydroxyethyl)phenyl)-2-Methylpropanoic acid
|
2-(4-(2-羥乙基)苯基)-2-甲基丙酸
|
552301-45-8
|
|
2-[1-(4-BROMOPHENYL)-1-METHYLETHYL]-4,4-DIMETHYL-4,5-DIHYDROOXAZOLINE
|
2-[1-(4-溴苯基)-1-甲基乙基]-4,5-二氫-4,4-二甲基惡唑
|
192775-97-6
|
|
tert-butyl 4-(1-(2-ethoxyethyl)-1H-benzo[d]imidazol-2-yl)piperidine-1-carboxylate
|
1-哌啶甲酸-4-[1-(2-乙氧基乙基)-1H-苯并咪唑-2-基]-1，1-二甲基乙酯
|
1181267-36-6
|
|
Oseltamivir Impurity1
|
奧司他韋雜質(zhì)1
|
3044729-56-5
|
|
2-[4-(2-[4-(1H-benzimidazol-2-yl])piperidin-1-yl]ethyl)phenyl]-2-methylpropionic acid
|
2-[4-(2-[4-(1H-苯并咪唑-2-基])哌啶-1-基]乙基)苯基]-2-甲基丙酸
|
2099128-83-1
|
|
methyl 2-methyl-2-(4-(2-(tosyloxy)ethyl)phenyl)propanoate
|
alpha，alpha-二甲基-4-[2-[[（4-甲基苯基）磺?；鵠氧基]乙基]苯乙酸甲酯
|
1181267-30-0
|
|
4-[1-(2-methoxy-ethyl)-1H-benzimidazole-2-yl]-piperidin-1-carboxylic acid tert-butyl ester
|
4-[1-(2-甲氧基-乙基)-1H-苯并咪唑-2-基]-哌啶-1-甲酸叔丁酯
|
1815602-35-7
|
|
4-methoxy-2,3,5-trimethylpyridine 1-oxide(SM2-3 )
|
2,3,5-三甲基-4-甲氧基吡啶氮氧化物(SM2-3 )
|
86604-80-0
|
|
Oseltamivir Impurity2
|
奧司他韋雜質(zhì)2
|
94154-89-9
|
|
Methyl 2-(4-(2-hydroxyethyl)phenyl)-2-methylpropionate
|
甲基2-（4-（2-羥基乙基）苯基）-2-甲基丙酸甲酯
|
1000536-33-3
|
|
N-nitroso-timolol
|
N-亞硝基噻嗎洛爾
|
|
|
2,4-Diaminoanisole
|
2,4-二氨基苯甲醚(SM1-8)
|
615-05-4
|
|
Phenylmethyl(3S,4S)-3-[2-[(ethoxycarbonyl)[5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-B]pyrazine-2-yl]amino]acetyl]-4 ethyl 1-pyrrolidincarboxylate
|
苯甲基(3S,4S)-3-[2-[(乙氧基羰基)[5-[(4-甲基苯基)磺?；鵠-5H-吡咯并[2,3-B]吡嗪-2-基]氨基]乙?；鵠-4 1-吡咯烷甲酸乙酯
|
2715120-95-7
|
|
4-Chloro-2-(propylthio)pyrimidine-5-amine (MDIP-15)
|
4-氯-2-(丙基硫代)嘧啶-5-胺(MDIP-15)
|
2518048-22-9
|
|
869 Impurity M
|
869雜質(zhì)M
|
185336-12-3
|
|
N-Nitroso Anatabine
|
N-亞硝基新煙堿
|
887407-16-1
|
|
N-Nitrosoanabasine
|
N-亞硝基假木賊堿
|
1133-64-8
|
|
4-(3-chloro-4-ureidophenoxy)-7-methoxyquinoline-6-carboxamide
|
4-(3-氯-4-脲基-苯氧基)-7-甲氧基-喹啉-6-羧酸酰胺
|
417719-51-8
|
|
2-Nitropropane-1,3-Diol
|
2-硝基-1，3-丙二醇鈉鹽
|
1794-90-7
|
|
2-Amino-6-chlorophenol
|
2-氨基-6-氯苯酚
|
38191-33-2
|
|
BM1-C
|
3,4-二氯-5-硝基苯甲酸
|
13300-63-5
|
|
Atenolol Impurity G
|
阿替洛爾雜質(zhì)G
|
56392-14-4
|
|
2-Chloro-4-(tert-pentyl)phenol
|
2-氯-4-叔戊基苯酚
|
5323-65-9
|
|
Ilaprazole
|
艾普拉唑
|
172152-36-2
|
|
Pentoxifylline Impurity J
|
己酮可可堿雜質(zhì)J
|
874747-30-5
|
|
3,4-Dichloro-7-methylquinoline-6-carboxamide
|
3,4-二氯-7-甲基喹啉 -6-甲酰胺
|
|
|
Isaconazole sulfate impurity BAL30078
|
硫酸艾沙康唑雜質(zhì)BAL30078
|
|
|
Afatinib maleate impurity I-G
|
馬來(lái)酸阿法替尼雜質(zhì)I-G
|
2983348-69-0
|
|
8-((3R,4S)-4-ethylpyrrolidine-3-yl)-N-(2,2,2-trifluoroethyl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine-3-carboxamide
|
8-((3R, 4S)-4-乙基吡咯烷-3-基)-N-(2,2,2-三氟乙基)-3H-咪唑并[1,2-a]吡咯并[2,3-e]吡嗪-3-甲酰胺
|
|
|
Dimeric 7-ACA
|
7-ACA二聚體
|
|
|
BGLT-18-Pioglitazone Impurity PGR-II.
|
BGLT-18-吡格列酮雜質(zhì)PGR-Ⅱ
|
|
|
(3R,4R)-3-(2-bromoacetyl)-4-ethylpyrrolidine-1-carboxylate
|
（3R，4R）-3-（2-溴乙?；?4-乙基吡咯烷-1-甲酸芐酯
|
|
|
BGLT-20-Pioglitazone Impurity PIO-II.
|
BGLT-20-吡格列酮雜質(zhì)PIO-Ⅱ
|
|
|
DL-Threitol
|
DL-蘇糖醇
|
7493-90-5
|
|
Afatinib Impurity des-EJA
|
阿法替尼雜質(zhì)DES-EJA
|
2223677-64-1
|
|
2-[3-[4-(3,4-dichlorophenyl)piperazine-1-yl]propyl][1,2,4]triazol[4,3-a]pyridine-3(2H)-one
|
2-[3-[4-（3,4-二氯苯基）哌嗪-1-基]丙基][1,2,4]三唑并[4,3-a]吡啶-3（2H）-酮
|
|
|
Posaconazole Impurity 35 (Oxalate)
|
泊沙康唑雜質(zhì)35（草酸鹽）
|
|
|
Ethyl 2-[(methoxycarbonylethyl)(toluene-4-sulfonyl)amino]methyl-4-phenoxybenzoate
|
2-[(甲氧基羰基乙基)(甲苯-4-磺酰)氨基]甲基-4-苯氧基苯甲酸乙酯
|
|
|
Ethyl 2-(chloromethyl)-4-phenoxybenzoate
|
2-(氯甲基)-4-苯氧基苯甲酸乙酯
|
|
|
2-Oxo-1,2-dihydro-[1,8]naphthyridine-3-carboxylic acid ethyl ester
|
2-氧-1,2-二氫-[1,8]萘啶-3-甲酸乙酯
|
5174-90-3
|
|
N-(2-PyridylMethyl)glycine Ethyl Ester
|
N-(2-吡啶甲基)甘氨酸乙酯
|
62402-24-8
|
|
Thioctic Acid Impurity H
|
硫辛酸雜質(zhì)H
|
188783-96-2
|